CoreAge Rx vs HealthRX
HealthRX's year and CoreAge's month arrive at the same annual total, which turns this into a question about when the money leaves your account.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
CoreAge Rx
Partner
$99/mo
Semaglutide runs $99 a month and tirzepatide $149, and neither figure moves as your dose climbs. The gap between the two molecules is the decision here: half again as much for tirzepatide, with the same flat treatment of the titration ladder.
- Price stated before any intake
- Same price at every dose, stated explicitly
- $50 step between molecules is below the market's typical gap
- All fifty states
- Auto-refill by default rather than opt-in
- No oral option
- Does not publish which compounding pharmacy supplies the product
Pick it for: Reaching the low rate without a year paid up front
Not for: Anyone wanting a tablet, or a seller that names its pharmacy.
HealthRX
Partner
$165/mo
Four plan lengths are priced in one table, each with its total, its per-month rate and its renewal rate. The advertised floor needs a full year paid up front; buying month to month is $165 for semaglutide and $214 for tirzepatide, held flat at every dose with nothing charged outside it.
- Four plan lengths priced, each with its total and its per-month rate
- One price at every dose, so titration carries no increase
- Consultation, prescription, medication and overnight shipping in the figure
- Full refund stated where a provider does not approve
- The annual table's $99 monthly equivalent requires $1,188 up front
- Month-to-month costs $165, two thirds more than the headline
- The compounding pharmacy is described but not named
- Injection only — no oral product on either molecule
Pick it for: Committing to twelve months and wanting every rung priced
Not for: Anyone who wants to stop after a month or two and needs the headline rate to hold.
Our verdict
HealthRX's recorded twelve-month plan table lists $1,188 upfront — the same total as twelve $99 monthly charges at CoreAge. That arithmetic does not make the payment schedules equivalent. HealthRX also separates its Subscribe & Save opening charge from the recurring rate and lists a subscriber credit in its renewal column. CoreAge's recorded monthly offer auto-refills until canceled. Compare the actual amount due now and renewal schedule for the selected plan; a shared annual total does not establish equal refund rights if treatment stops early.
What actually separates them
CoreAge Rx and HealthRX differ on published price and where you can use it. The table summarizes those terms; confirm any details it does not cover with the provider.
HealthRX’s comparison figure is $66 higher than CoreAge Rx’s — a 67% difference between the listed rates. These figures do not establish equivalent prescribed doses, supply or care. Confirm the selected product, full payment obligation and next charge.
At unchanged rates, a twelve-month illustration is about $1,188 at CoreAge Rx against $1,980 at HealthRX — a difference of $792. This is not a quote for a year of care: actual charges depend on prescribed supply, purchase terms and renewals.
| CoreAge Rx | HealthRX | |
|---|---|---|
| Published price | $99/mo | $165/mo |
| Where you can use it | 50 states | All 50 states |
Before you choose either
Whether these two publish a milligram dose is not settled in our records for both of them, so treat the two prices as not yet comparable and ask each what dose the monthly figure buys. Set the answers against every published price we hold — a lower monthly price at a smaller dose is not the cheaper option.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.